SEC EDGAR · Insider purchase
RAPP: PAUL STEVEN M reported buying shares
1 reported purchase of non-derivative securities. Code P includes open-market and private purchases; it does not establish motive.
Follow RAPP- Became public
- Oct 22, 2026
- Event / period date
- Oct 22, 2026
- Collected
- Nov 8, 2026, 7:56 PM EST
Why this is connected
This filing identifies Rapport Therapeutics, Inc. as the issuer of the security. The company's SEC identifier connects it to RAPP.
Reported transactions
PAUL STEVEN M (Director)
35,714 shares · Common Stock
Oct 22, 2026 · $27.28 per share
Value calculated from the reported shares and prices: $974,277.92.
Code P covers open-market and private purchases. Grants, option exercises, and tax withholding are excluded from purchase results. Read the source footnotes for ownership and pricing details.
Source evidence
Read the source excerpt or record
<?xml version="1.0"?>
<ownershipDocument>
<schemaVersion>X0609</schemaVersion>
<documentType>4</documentType>
<periodOfReport>2026-10-22</periodOfReport>
<issuer>
<issuerCik>0002012593</issuerCik>
<issuerName>Rapport Therapeutics, Inc.</issuerName>
<issuerTradingSymbol>RAPP</issuerTradingSymbol>
<issuerForeignTradingSymbol></issuerForeignTradingSymbol>
</issuer>
<reportingOwner>
<reportingOwnerId>
<rptOwnerCik>0001237564</rptOwnerCik>
<rptOwnerName>PAUL STEVEN M</rptOwnerName>
</reportingOwnerId>
<reportingOwnerAddress>
<rptOwnerNonUSAddressFlag>false</rptOwnerNonUSAddressFlag>
<rptOwnerStreet1>RAPPORT THERAPEUTICS, INC.</rptOwnerStreet1>
<rptOwnerStreet2>99 HIGH STREET, SUITE 2100</rptOwnerStreet2>
<rptOwnerCity>BOSTON</rptOwnerCity>
<rptOwnerState>MA</rptOwnerState>
<rptOwnerZipCode>02110</rptOwnerZipCode>
<rptOwnerStateDescription></rptOwnerStateDescription>
</reportingOwnerAddress>
<reportingOwnerRelationship>
<isDirector>true</isDirector>
<isOfficer>false</isOfficer>
<isTenPercentOwner>false</isTenPercentOwner>
<isOther>false</isOther>
</reportingOwnerRelationship>
</reportingOwner>
<aff10b5One>false</aff10b5One>
<nonDerivativeTable>
<nonDerivativeTransaction>
<securityTitle>
<value>Common Stock</value>
</securityTitle>
<transactionDate>
<value>2026-10-22</value>
</transactionDate>
<transactionCoding>
<transactionFormType>4</transactionFormType>
<transactionCode>P</transactionCode>
<equitySwapInvolved>false</equitySwapInvolved>
</transactionCoding>
<transactionAmounts>
<transactionShares>
<value>35714</value>
</transactionShares>
<transactionPricePerShare>
<value>27.28</value>
<footnoteId id="F1"/>
</transactionPricePerShare>
<transactionAcquiredDisposedCode>
<value>A</value>
</transactionAcquiredDisposedCode>
</transactionAmounts>
<postTransactionAmounts>
<sharesOwnedFollowingTransaction>
<value>77380</value>
</sharesOwnedFollowingTransaction>
</postTransactionAmounts>
<ownershipNature>
<directOrIndirectOwnership>
<value>I</value>
</directOrIndirectOwnership>
<natureOfOwnership>
<value>By Paul Capital Strategy III Fund LLC</value>
<footnoteId id="F2"/>
</natureOfOwnership>
</ownershipNature>
</nonDerivativeTransaction>
<nonDerivativeHolding>
<securityTitle>
<value>Common Stock</value>
</securityTitle>
<postTransactionAmounts>
<sharesOwnedFollowingTransaction>
<value>477642</value>
</sharesOwnedFollowingTransaction>
</postTransactionAmounts>
<ownershipNature>
<directOrIndirectOwnership>
<value>D</value>
</directOrIndirectOwnership>
</ownershipNature>
</nonDerivativeHolding>
</nonDerivativeTable>
<footnotes>
<footnote id="F1">The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $26.87 to $27.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected.</footnote>
<footnote id="F2">Shares held by Paul Capital Strategy III Fund LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any.</footnote>
</footnotes>
<ownerSignature>
<signatureName>/s/ Troy Ignelzi, Attorney-in-Fact</signatureName>
<signatureDate>2026-10-22</signatureDate>
</ownerSignature>
</ownershipDocument>Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.